We’re at ESMO - European Society for Medical Oncology 2025! 🎗️ Stop by booth 4003 to see how QP-Insights helps you manage your data throughout the entire care process. Our platform turns complex data into clear, actionable insights, enabling precision medicine and streamlining clinical workflows from start to finish. Come meet Ana Jimenez Pastor, Claire Palacin, Paula Moreno Ruiz, Anna Nogué Infante and the rest of the team and discover how images and multi-omic data can accelerate smarter decision-making in cancer research. 📅 Book a demo: https://bit.ly/4nZyKQB #ESMO25 #Oncology #ClinicalTrials #Imaging
Our team will participate in the latest webinar from Prostate Cancer Research, "𝘛𝘩𝘦 𝘧𝘶𝘵𝘶𝘳𝘦 𝘰𝘧 𝘗𝘳𝘰𝘴𝘵𝘢𝘵𝘦 𝘊𝘢𝘯𝘤𝘦𝘳 𝘐𝘮𝘢𝘨𝘪𝘯𝘨: 𝘞𝘩𝘢𝘵'𝘴 𝘕𝘦𝘹𝘵?", the perfect opportunity to discover how AI is transforming MRI and clinical workflows, from better diagnoses to smarter care. 🗓 November 25, 2025 | 6:00-7:15 p.m. 📍 Register at https://lnkd.in/dzNmxnpS Speakers: • David Bazaga (Quibim) • Antony Rix (Lucida Medical) • Jana Schulte (NHS InSites Programme) #ProstateCancer #MedicalImaging #AIinHealthcare #NHS #Oncology #Radiology #Webinar
Two MRI images. Two scanners. One harmonized, one not. To the naked eye, it may seem subtle, but for AI, those differences can mean a loss of accuracy, reproducibility, and confidence. That's why Quibim's image harmonization process standardizes images across all centers and protocols, ensuring: ✅ Reliable biomarkers. ✅ More robust AI generalization. ✅ Consistency in multicenter trials. Because your AI shouldn't have to detect the differences. https://bit.ly/4q8Zfou #Medicalimaging #AI hashtag#MRI #Clinicaltrials #Healthcareinnovation
Today, Prostate Cancer Research, an organization we proudly collaborate with, presented a report to the House of Commons outlining how a #ProstateCancer screening program could be implemented. The report covers everything from the NHS’s capacity and resources to identifying high-risk men, all while minimizing the burden on primary care physicians. Why does this matter? The more practical and achievable the plan, the closer we get to a national screening program. Make your voice heard: pcr.org.uk/screening #EarlyDetection #MedicalInnovation #HealthcareResearch
We're at Society for Advanced Body Imaging - SABI in Nashville until October 15! Visit booth 7 and meet Joshua Moss, Edward Ramirez R.T. (R)(MR) B.S., and Eric Draper to see how QP-Prostate leverages AI to optimize fusion biopsy and focal therapy procedures. Don't miss the opportunity to book a demo and see how we our platform is setting a new standard for accuracy, speed, and diagnostic precision: https://lnkd.in/d22MA8ph #MedicalImaging #AIinHealthcare #Radiology #SABI2025
Attending FOCAL+ in Washington? We’d be glad to meet you. Stop by our booth to explore QP-Prostate in action — our AI-powered solution transforming prostate cancer screening and streamlining radiology workflows. Our team, Ángel Alberich-Bayarri, David Bazaga, Nathan Clark, and Edward Ramirez R.T. (R)(MR) B.S., are onsite to connect, share insights, and demonstrate how AI is driving real impact in patient care. 📩 Don't forget to book a demo: 👉 https://lnkd.in/dgrFesA2 #MedicalImaging #AIinHealthcare #Radiology #FOCAL2025
In our latest interview, Dr. Noelia Tarazona MD, PhD (Mass General Brigham & INCLIVA Instituto de Investigación Sanitaria) shares how translational research is turning precision oncology into everyday clinical practice — highlighting the impact of advances such as circulating tumor DNA (ctDNA) and radiomics, or going into detail about the systemic changes needed to achieve equitable access to innovation across Europe. 💬 As we approach #ESMO2025, discover how research and patient care can advance together toward truly personalized medicine. Read the full conversation 👉 https://bit.ly/4h5GjD8 #Oncology #PrecisionMedicine #LiquidBiopsy #Radiomics #CancerResearch #CancerResearch
#BreastCancer remains the most common cancer among women worldwide, with 2.3 million new cases each year. Given this burden, improving survival depends on early detection and accurate diagnosis. Advances in imaging and artificial intelligence are opening up new possibilities across the healthcare pathway—from early detection and diagnostic accuracy to treatment response prediction. During #BreastCancerAwarenessMonth, we highlight some innovations that are driving progress against this disease and how with QP-Breast we are committed to bringing these breakthroughs into clinical practice. #BreastCancerAwareness #AIinHealthcare #MedicalImaging
We’re honored to receive the 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘊𝘰𝘮𝘱𝘢𝘯𝘺 of 2025 award at the XIII Edition of the FORO EMPRESAS INNOVADORAS (FEI) — an event that celebrates organizations driving economic, social, and scientific progress. This recognition reinforces our commitment to advancing medical imaging and AI to transform healthcare and improve patient outcomes. Thank you to the FEI for this meaningful acknowledgment. #InnovativeCompanies #FEI2025 #HealthcareAI #PrecisionMedicine
🇺🇸 Our team will be present at two key events this October to connect, exchange insights, and showcase how our AI technology is transforming medical imaging. 📍 FOCAL+ — Washington, D.C. | October 9–11 👉 https://lnkd.in/dgrFesA2 📍 Society for Advanced Body Imaging - SABI — Nashville | October 11–15 👉 https://lnkd.in/d22MA8ph If you’re attending, schedule a meeting with our team and discover how we’re advancing precision imaging and patient care. David Bazaga Nathan Clark Joshua Moss Eric Draper Edward Ramirez R.T. (R)(MR) B.S. #MedicalImaging #AIinHealthcare #Radiology #FOCAL2025 #SABI2025
